3644 results for «2918»

Filter By

3644 results

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

PCR Tokyo Valves 2024 Welcome Ceremony

Valve-in-Valve

17 Feb 2024 – From PCR Tokyo Valves 2024

Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve

New possibilities in TEER

18 Feb 2024 – From PCR Tokyo Valves 2024

Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...

New possibilities in

The role of WATCHMAN therapy in optimising results and future perspectives

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.

Mitral and tricuspid intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!

Solving challenging PCI with laser atherectomy: the forgotten Swiss knife?

15 May 2024 – From EuroPCR 2024

Watch this session to enhance your understanding of laser atherectomy fundamentals, recognize its role in addressing complex lesions like in-stent restenosis and uncrossable lesions, and acquire tips and techniques for ensuring procedural efficiency and safety.

Solving challenging PCI with laser atherectomy; the forgotten Swiss knife?

uRDN now - The third pillar for hypertension treatment

16 May 2024 – From EuroPCR 2024

Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...

uRDN now - The third pillar for hypertension treatment

Robotic PCI: tips and tricks, challenging anatomies and future perspectives

14 May 2024 – From EuroPCR 2024

In this session, discover the effectiveness and safety of robotic PCI for both simple and complex lesions requiring additional devices like IVL, IVUS, laser, and FFR. Learn about the numerous benefits of robotics for patients and cathlab teams, including enhanced precision in wire navigation and stent...

Robotic PCI: tips and tricks, challenging anatomies and future perspectives

Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes

16 May 2024 – From EuroPCR 2024

Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...

Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes

Relief for the unrelievable: the role of the Reducer for refractory angina

15 May 2024 – From EuroPCR 2024

Explore the incidence and impact of refractory angina, observe a real-life Reducer implantation procedure with step-by-step analysis and discussions, gain insight into the coronary sinus mechanism of action and implantation techniques, grasp the indications for the Reducer, and review available clinical data in this session.

Relief for the unrelievable, the role of the Reducer for refractory angina

Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions

16 May 2024 – From EuroPCR 2024

Explore this EuroPCR 2024 session for a comprehensive understanding of the imaging pathway in transcatheter tricuspid valve interventions, including diagnosis, therapy, and post-procedural follow-up, discover innovative, transformative imaging techniques such as 4D intracardiac echocardiography and dual-source photon-counting CT, and learn how these innovations can be applied in...

Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions

Left main and complex bifurcation stenting

14 May 2024 – From EuroPCR 2024

Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...

Left main and complex bifurcation stenting

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

15 May 2024 – From EuroPCR 2024

This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024 – From EuroPCR 2024

This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...

LANDMARK RCT - Early

The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment

14 May 2024 – From EuroPCR 2024

Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...

The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment
Didn’t find what you were looking for?